-
Biogen Shares Gain On Midstage Results For Alzheimer's Candidate
Wednesday, July 25, 2018 - 2:59pm | 435Read More...Biogen Inc (NASDAQ: BIIB) shares, which ended Tuesday's session at a three-year high following a beat-and-raise second-quarter report, are experiencing continued momentum after a poster presentation on the company's Alzheimer's disease candidate co-developed with Japan's...
-
Has Eli Lilly Found A Cure For Alzheimer's?
Monday, July 20, 2015 - 11:57am | 375Read More...Shares of Eli Lilly and Co (NYSE: LLY) have risen 26 percent over the past year, in large part due to speculation that the company could become the first pharmaceutical firm to roll out a treatment for Alzheimer's disease. This week, the company is set to present the results of its clinical trials...
-
Stifel, JMP Securities Discuss What To Expect From AAIC Conference
Monday, July 20, 2015 - 8:30am | 464Read More...In a report published Monday, JMP Securities analyst Michael King discussed the potential upside for the biotech sector ahead of the upcoming Alzheimer's Association International Conference (AAIC) that will take place July 18 through July 23 in Washington, D.C. King noted various media...
